These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25602964)

  • 1. Costs of cancer care for use in economic evaluation: a UK analysis of patient-level routine health system data.
    Hall PS; Hamilton P; Hulme CT; Meads DM; Jones H; Newsham A; Marti J; Smith AF; Mason H; Velikova G; Ashley L; Wright P
    Br J Cancer; 2015 Mar; 112(5):948-56. PubMed ID: 25602964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic burden of cancer in the UK: a study of survivors treated with curative intent.
    Marti J; Hall PS; Hamilton P; Hulme CT; Jones H; Velikova G; Ashley L; Wright P
    Psychooncology; 2016 Jan; 25(1):77-83. PubMed ID: 26087260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of financial difficulties and out-of-pocket payments with health-related quality of life among breast, prostate and colorectal cancer patients.
    Koskinen JP; Färkkilä N; Sintonen H; Saarto T; Taari K; Roine RP
    Acta Oncol; 2019 Jul; 58(7):1062-1068. PubMed ID: 30943813
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of trends in the cost of initial cancer treatment.
    Warren JL; Yabroff KR; Meekins A; Topor M; Lamont EB; Brown ML
    J Natl Cancer Inst; 2008 Jun; 100(12):888-97. PubMed ID: 18544740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New analysis reexamines the value of cancer care in the United States compared to Western Europe.
    Soneji S; Yang J
    Health Aff (Millwood); 2015 Mar; 34(3):390-7. PubMed ID: 25732488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic disparities in treatment costs among ambulatory Medicaid cancer patients.
    Mullins CD; Snyder SE; Wang J; Cooke JL; Baquet C
    J Natl Med Assoc; 2004 Dec; 96(12):1565-74. PubMed ID: 15622686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validating the use of Hospital Episode Statistics data and comparison of costing methodologies for economic evaluation: an end-of-life case study from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP).
    Thorn JC; Turner EL; Hounsome L; Walsh E; Down L; Verne J; Donovan JL; Neal DE; Hamdy FC; Martin RM; Noble SM;
    BMJ Open; 2016 Apr; 6(4):e011063. PubMed ID: 27130167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcoma epidemiology and cancer-related hospitalisation in Western Australia from 1982 to 2016: a descriptive study using linked administrative data.
    Wright CM; Halkett G; Carey Smith R; Moorin R
    BMC Cancer; 2020 Jul; 20(1):625. PubMed ID: 32631311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer outcomes in low-income elders: is there an advantage to being on Medicaid?
    Koroukian SM; Bakaki PM; Owusu C; Earle CC; Cooper GS
    Medicare Medicaid Res Rev; 2012; 2(2):. PubMed ID: 24800139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Annual Medical Expenditure and Productivity Loss Among Colorectal, Female Breast, and Prostate Cancer Survivors in the United States.
    Zheng Z; Yabroff KR; Guy GP; Han X; Li C; Banegas MP; Ekwueme DU; Jemal A
    J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26705361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in cancer survival and patterns of care across Europe: roles of wealth and health-care organization.
    Gatta G; Trama A; Capocaccia R
    J Natl Cancer Inst Monogr; 2013; 2013(46):79-87. PubMed ID: 23962511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Out-of-pocket medical expenses compared across five years for patients with one of five common cancers in Australia.
    Rodriguez-Acevedo AJ; Chan RJ; Olsen CM; Pandeya N; Whiteman DC; Gordon LG
    BMC Cancer; 2021 Sep; 21(1):1055. PubMed ID: 34563142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost of care for elderly cancer patients in the United States.
    Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
    J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective.
    Sagar B; Lin YS; Castel LD
    J Med Econ; 2017 Oct; 20(10):1018-1023. PubMed ID: 28581874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation.
    Robertson C; Arcot Ragupathy SK; Boachie C; Dixon JM; Fraser C; Hernández R; Heys S; Jack W; Kerr GR; Lawrence G; MacLennan G; Maxwell A; McGregor J; Mowatt G; Pinder S; Ternent L; Thomas RE; Vale L; Wilson R; Zhu S; Gilbert FJ
    Health Technol Assess; 2011 Sep; 15(34):v-vi, 1-322. PubMed ID: 21951942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal post-treatment surveillance in cancer survivors: is more really better?
    Shah M; Denlinger CS
    Oncology (Williston Park); 2015 Apr; 29(4):230-40. PubMed ID: 25952485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating Costs of Care Attributable to Cancer: Does the Choice of Comparison Group Matter?
    Chen AB; Li L; Cronin AM; Brooks GA; Kavanagh BD; Schrag D
    Health Serv Res; 2018 Aug; 53 Suppl 1(Suppl Suppl 1):3227-3244. PubMed ID: 28858372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer.
    Reyes C; Engel-Nitz NM; DaCosta Byfield S; Ravelo A; Ogale S; Bancroft T; Anderson A; Chen M; Matasar M
    Oncologist; 2019 Sep; 24(9):1209-1218. PubMed ID: 30796156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Access denied: The relationship between patient insurance status and access to high-volume hospitals.
    Nabi J; Tully KH; Cole AP; Marchese M; Cone EB; Melnitchouk N; Kibel AS; Trinh QD
    Cancer; 2021 Feb; 127(4):577-585. PubMed ID: 33084023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship Between Quality of Comorbid Condition Care and Costs for Cancer Survivors.
    Frick KD; Snyder CF; Herbert RJ; Blackford AL; Neville BA; Wolff AC; Carducci MA; Earle CC
    J Oncol Pract; 2016 Jun; 12(6):e734-45. PubMed ID: 27165487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.